Contribute Try STAT+ Today

WASHINGTON — Just months after lawmakers on the Energy and Commerce Committee lavished praise on each other for passing a slew of drug pricing bills, that committee’s efforts to deal with the issue are quickly descending into partisan chaos.

At a hearing Wednesday, Republicans accused Democrats of sabotaging bipartisan efforts to lower the cost of prescription drugs. At times, both parties were tripping over themselves to lob attacks and complain. And at one point, they were openly bickering about their respective speaking time.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.